Santen Pharmaceutical Co (4536N) Q1 2022 Earnings Report

0 Followers

MX:4536N Q1 2022 EPS Results

Actual EPS: MXN 1.97
Consensus EPS: MXN 223.57
Beat/Miss: Missed by -MXN 221.60
One Year Ago EPS: MXN 2.16

MX:4536N Q1 2022 Revenue Results

Actual Revenue: MXN 7.67B
Expected Revenue: MXN 1.14T
Beat/Miss: Missed by -MXN 1.13T
YoY Revenue Growth: +0.84%

Earnings Announcement Details

Quarter: Q1 2022
Date: 08/04/2022
Time: TBA
Conference Call: Thursday, August 4, 2022

MX:4536N Upcoming Earnings

Santen Pharmaceutical Co's next earnings date is estimated for February 9, 2027, based on past reporting schedules.

Q1 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q1 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q1 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

MX:4536N Earnings History

MX:4536N earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Feb 09, 2027	2026 (Q3)	4.41-	2.86	―	―
Nov 05, 2026	2026 (Q2)	3.663.01	2.86	5.03% (+0.14)
Aug 06, 2026	2026 (Q1)	2.492.62	2.03	29.21% (+0.59)
May 12, 2026	2025 (Q4)	3.615.61	3.02	85.80% (+2.59)
Feb 05, 2026	2025 (Q3)	3.432.86	2.97	-3.67% (-0.11)
Nov 06, 2025	2025 (Q2)	2.452.86	2.73	4.94% (+0.13)
Aug 07, 2025	2025 (Q1)	2.802.03	3.47	-41.47% (-1.44)
May 13, 2025	2024 (Q4)	2.033.02	1.92	57.30% (+1.10)
Feb 06, 2025	2024 (Q3)	3.062.97	2.37	25.40% (+0.60)
Nov 07, 2024	2024 (Q2)	2.542.73	2.83	-3.48% (-0.10)
Aug 06, 2024	2024 (Q1)	3.043.47	3.27	5.94% (+0.19)
May 09, 2024	2023 (Q4)	2.051.92	0.3	547.55% (+1.62)
Feb 08, 2024	2023 (Q3)	1.962.37	1.75	35.39% (+0.62)
Nov 07, 2023	2023 (Q2)	1.542.83	-8.53	133.13% (+11.36)
Aug 03, 2023	2023 (Q1)	1.673.27	1.97	66.35% (+1.30)
May 11, 2023	2022 (Q4)	0.270.30	2.3	-87.14% (-2.01)
Feb 07, 2023	2022 (Q3)	1.401.75	1.48	18.41% (+0.27)
Nov 08, 2022	2022 (Q2)	―-8.53	2.03	-520.55% (-10.56)
Aug 04, 2022	2022 (Q1)	―1.97	2.16	-8.95% (-0.19)
May 10, 2022	2021 (Q4)	―2.30	-4.19	155.00% (+6.50)
Feb 10, 2022	2021 (Q3)	―1.48	2.14	-31.07% (-0.67)
Nov 08, 2021	2021 (Q2)	―2.03	2.24	-9.27% (-0.21)
Aug 06, 2021	2021 (Q1)	―2.16	1.81	19.04% (+0.35)
May 11, 2021	2020 (Q4)	―-4.19	0.97	-531.14% (-5.16)
Feb 04, 2021	2020 (Q3)	―2.14	2.1	2.01% (+0.04)
Nov 06, 2020	2020 (Q2)	―2.24	1.98	12.89% (+0.26)
Aug 05, 2020	2020 (Q1)	―1.81	1.88	-3.37% (-0.06)
May 08, 2020	2019 (Q4)	―1.41	3.61	-60.82% (-2.19)
Feb 04, 2020	2019 (Q3)	―3.07	3.65	-15.82% (-0.58)
Nov 06, 2019	2019 (Q2)	―2.94	3.09	-4.82% (-0.15)
Aug 01, 2019	2019 (Q1)	―2.72	2.86	-5.19% (-0.15)
May 09, 2019	2018 (Q4)	―3.61	3.35	7.78% (+0.26)
Feb 05, 2019	2018 (Q3)	―3.65	4.89	-25.48% (-1.25)
Nov 07, 2018	2018 (Q2)	―3.09	2.57	20.29% (+0.52)
Aug 01, 2018	2018 (Q1)	―2.86	3.68	-22.22% (-0.82)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed

Santen Pharmaceutical Co earnings date